Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$342,562,263
New position
Shares Held
1,736,955
first reported quarter
Ownership
0.112%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 4.295275352556629.ToString("F0")%
Shared 0.ToString("F0")%
None 95.70472464744337.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $9,418,688,045 across 17 Drug Manufacturers - General names. AZN ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,238,839 | $2,502,781,802 | |
| 2 | ABBV |
AbbVie Inc.
|
9,604,349 | $2,088,849,862 | |
| 3 | LLY |
ELI LILLY & Co
|
1,625,655 | $1,495,228,697 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,585,514 | $792,171,477 | |
| 5 | AMGN |
Amgen Inc
|
1,620,353 | $570,121,202 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,561,652 | $357,017,436 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,736,955 | $342,562,263 | |
| 8 | PFE |
Pfizer Inc
|
11,674,216 | $327,811,983 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $342,562,263 | 1,736,955 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||